HSCA Comments on FDA “Risk Management Plans to Mitigate the Potential for Drug Shortages” Draft Guidance
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we appreciate the opportunity to comment on the Food and Drug Administration’s (FDA) “Risk Management Plans to Mitigate the Potential for Drug Shortages” draft guidance.
Click here to read the full comments.
Related Posts
HSCA Applauds House Judiciary Committee for Advancing the CREATES Act
April 30, 2019
Washington, DC (April 30, 2019) – Healthcare Supply Chain Association (HSCA)...
HSCA Applauds Senators Collins and Smith for Bipartisan Legislation to Prevent and Mitigate Drug Shortages
October 30, 2019
Washington, DC (October 30, 2019) – Healthcare Supply Chain Association (HSCA)...
Joint Letter of Support for the MEDS Act
November 5, 2019
Dear Senator Collins and Senator Smith, The undersigned organizations are...
HSCA Statement on Senate HELP Committee Hearing on the Coronavirus
March 3, 2020
Washington, DC (March 3, 2020) – Healthcare Supply Chain Association (HSCA)...